U.S. Markets open in 6 hrs 14 mins

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
43.64-0.01 (-0.02%)
At close: 4:01PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close43.65
Bid0.00 x
Ask0.00 x
Day's Range43.50 - 43.75
52 Week Range36.76 - 45.84
Avg. Volume7,375,847
Market Cap75.41B
PE Ratio (TTM)45.41
Earnings DateN/A
Dividend & Yield1.06 (2.43%)
Ex-Dividend Date2017-04-12
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters3 days ago

    Global med-tech firms, India locked in tussle after stent price sting

    NEW DELHI/MUMBAI, April 28 (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent.

  • Benzinga5 days ago

    Global Market For Medical Implants To Hit Nearly $27 Billion In 5 Years

    The market for implantable medical devices — pacemakers, defibrillators, hearing aids and other machines that help the body run — is expected to hit $26.75 billion by 2022, according to a new market research ...

  • Cramer's lightning round: Nobody ever made money betting against this CEO
    CNBC6 days ago

    Cramer's lightning round: Nobody ever made money betting against this CEO

    Jim Cramer rattles off his take on caller favorite stocks, including this health care giant.